Bio-Path Holdings Inc (BPTH)
2.635
+0.14
(+5.82%)
USD |
NASDAQ |
Apr 25, 16:00
2.66
+0.02
(+0.95%)
Pre-Market: 09:01
Bio-Path Holdings Shareholders Equity (Quarterly): 0.441M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.441M |
September 30, 2023 | 2.525M |
June 30, 2023 | 5.043M |
March 31, 2023 | 9.107M |
December 31, 2022 | 14.17M |
September 30, 2022 | 16.20M |
June 30, 2022 | 19.52M |
March 31, 2022 | 22.32M |
December 31, 2021 | 25.46M |
September 30, 2021 | 29.35M |
June 30, 2021 | 29.75M |
March 31, 2021 | 31.37M |
December 31, 2020 | 15.07M |
September 30, 2020 | 13.19M |
June 30, 2020 | 16.01M |
March 31, 2020 | 17.93M |
December 31, 2019 | 21.09M |
September 30, 2019 | 16.02M |
June 30, 2019 | 17.91M |
March 31, 2019 | 20.14M |
December 31, 2018 | 1.218M |
September 30, 2018 | 2.988M |
June 30, 2018 | 4.737M |
March 31, 2018 | 6.275M |
December 31, 2017 | 8.067M |
Date | Value |
---|---|
September 30, 2017 | 6.549M |
June 30, 2017 | 8.855M |
March 31, 2017 | 8.092M |
December 31, 2016 | 8.24M |
September 30, 2016 | 9.377M |
June 30, 2016 | 6.327M |
March 31, 2016 | 8.046M |
December 31, 2015 | 9.818M |
September 30, 2015 | 11.19M |
June 30, 2015 | 12.60M |
March 31, 2015 | 13.63M |
December 31, 2014 | 14.92M |
September 30, 2014 | 16.00M |
June 30, 2014 | 17.03M |
March 31, 2014 | 18.18M |
December 31, 2013 | 4.784M |
September 30, 2013 | 5.577M |
June 30, 2013 | 3.477M |
March 31, 2013 | 1.680M |
December 31, 2012 | 2.014M |
September 30, 2012 | 1.802M |
June 30, 2012 | 1.922M |
March 31, 2012 | 2.462M |
December 31, 2011 | 2.915M |
September 30, 2011 | 3.199M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.441M
Minimum
Dec 2023
31.37M
Maximum
Mar 2021
16.97M
Average
16.20M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | 266.32M |
INVO Bioscience Inc | 0.8928M |
SINTX Technologies Inc | 8.772M |
Aileron Therapeutics Inc | 6.887M |
NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.22M |
Total Liabilities (Quarterly) | 2.779M |